alexa Hepatic Steatosis|omicsgroup|Journal Of Diabetes And Metabolism

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Hepatic Steatosis Innovations

Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that breaks into¬Ě the market or society. Hepatic Steatosis is referred to fatty liver which is caused due to the excessive amount accumulation of triglycerides and other types of fats. The major cause of the hepatic steatosis is consumption of alcohol in high amount which directly affects liver cells. Other risk factors for the development of fatty liver are type 2 diabetes, insulin resistance and high cholesterol. Steatosis is more common in women, and may also appear in thin people with low alcohol intake in smaller proportions. Both hepatic steatosis and steatohepatitis and cause no symptoms (they are asymptomatic) in early stages and are usually discovered incidentally in ultrasound or CT scans. The condition is generally not painful and may go unnoticed for a long period of time. In severe cases, the liver can increase to over three times its normal size and may be painful and tender.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2014

Top